CDXS Logo 2 April 2021.jpg
Codexis to Participate in the Cowen 42nd Annual Health Care Conference
March 01, 2022 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management...
CDXS Logo 2 April 2021.jpg
Codexis Reports Fourth Quarter and Fiscal Year 2021 Financial Results
February 24, 2022 16:05 ET | Codexis, Inc.
Record Annual Total Revenue of $104.8M, Representing Eighth Consecutive Year of Revenue Growth Company Guides to 2022 Total Revenues of $152-$158M; Product Revenues of $112-$118M REDWOOD CITY,...
CDXS Logo 2 April 2021.jpg
Codexis to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24
February 10, 2022 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that it will...
CDXS Logo 2 April 2021.jpg
Codexis Announces FDA Orphan Drug and Rare Pediatric Disease Designations for CDX 6512 for the Treatment of Homocystinuria
January 24, 2022 08:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that the U.S....
CDXS Logo 2 April 2021.jpg
Codexis to Participate in the H.C. Wainwright Virtual BioConnect Conference
January 05, 2022 08:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management...
CDXS Logo 2 April 2021.jpg
Codexis Launches Codex® HiTemp Reverse Transcriptase to Address Key Challenges in One-Step Assays for RNA Detection in PCR Testing, including COVID-19 Testing
December 15, 2021 08:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the launch of...
CDXS Logo 2 April 2021.jpg
Codexis Presents Pre-Clinical Data Highlighting its Programs in Homocystinuria and Maple Syrup Urine Disease at ICIEM 2021
November 22, 2021 08:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that two of the...
CDXS Logo 2 April 2021.jpg
Codexis to Participate in Upcoming Virtual Healthcare Conferences
November 19, 2021 08:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Codexis, inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management...
CDXS Logo 2 April 2021.jpg
Codexis Appoints Two New Senior Leaders for Human Resources and Corporate Development
November 15, 2021 08:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the appointments...
CDXS Logo 2 April 2021.jpg
Codexis to Present Data Highlighting Two New Therapeutic Discovery Programs at the 14th International Congress of Inborn Errors of Metabolism 2021
November 15, 2021 08:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Codexis, inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced two oral...